Assyro AI

Title 21 CFR reference

Explore the full hierarchy of this title across chapters, subchapters, and parts.

Select a part from the tree to begin

Browse chapters and parts on the left to load sections

United States • Title 21 CFR • Part 13

Part 13PART 13—PUBLIC HEARING BEFORE A PUBLIC BOARD OF INQUIRY

Part 13 outlines the procedures for public hearings before a Public Board of Inquiry (Board) established by the FDA Commissioner. These hearings are discretionary and may be held when deemed in the public interest, when mandated by specific regulations, or when a party waives a formal evidentiary hearing and requests the Board act as an administrative law tribunal. The part details the notice of hearing, selection and qualifications of Board members, separation of functions, submission procedures, disclosure of data, conduct of proceedings, and the administrative record.

What this part covers

  • Establishes procedures for public hearings before a Public Board of Inquiry (Board) at the FDA.
  • Hearings can be initiated at the Commissioner's discretion, by specific regulations, or upon waiver of a formal evidentiary hearing.
  • Details the process for publishing a notice of hearing, including required information.
  • Specifies qualifications for Board members, emphasizing medical, technical, and scientific expertise, and freedom from bias.
  • Outlines the nomination and selection process for Board members, involving FDA centers, parties, and the Commissioner.
  • Addresses separation of functions and ex parte communications to ensure impartiality.
  • Governs the submission of documents and information to the Board, including service requirements and confidentiality.
  • Defines the conduct of proceedings as a scientific inquiry, not a legal trial, with informal rules of evidence.
  • Describes the composition and accessibility of the administrative record, which serves as the exclusive record for decision.
  • Specifies that all hearings are transcribed and generally open to the public, with exceptions for executive sessions.

Sections in Part 13

§ 13.1

Scope.

The procedures in this part apply when— Board(a) The Commissioner concludes, as a matter of discretion, that it is in the public interest to hold a public hearing before a Public Board of Inquiry () with respect to any matter before FDA; (b) Under specific sections of this chapter a matter before FDA is subject to a hearing before a Board; or (c) Under § 12.32, a person who has a right to an opportunity for a formal evidentiary public hearing waives that opportunity and requests that a Board act as an administrative law tribunal concerning the matters involved, and the Commissioner decides to accept this request.

§ 13.10

Members of a Board.

(a) All members of a Board are to have medical, technical, scientific, or other qualifications relevant to the issues to be considered, are subject to the conflict of interest rules applicable to special Government employees, and are to be free from bias or prejudice concerning the issues involved. A member of a Board may be a full-time or part-time Federal Government employee or may serve on an FDA advisory committee but, except with the agreement of all parties, may not currently be a full-time or part-time employee of FDA or otherwise act as a special Government employee of FDA. (b) Within 30 days of publication of the notice of hearing, the director of the center of FDA responsible for a matter before a Board, the other parties to the proceeding, and any person whose petition was granted and is the subject of the hearing, shall each submit to the Division of Dockets Management the names and full curricula vitae of five nominees for members of the Board. Nominations are to state that the nominee is aware of the nomination, is interested in becoming a member of the Board, and appears to have no conflict of interest. (1) Any two or more persons entitled to nominate members may…

§ 13.15

Separation of functions; ex parte communications; administrative support.

(a) The proceeding of a Board are subject to the provisions of § 10.55 relating to separation of functions and ex parte communications. Representatives of the participants in any proceeding before a Board, including any members of the office of the Chief Counsel of FDA assigned to advise the center responsible for the matter, may have no contact with the members of the Board, except as participants in the proceeding, and may not participate in the deliberations of the Board. (b) Administrative support for a Board is to be provided only by the office of the Commissioner and the office of the Chief Counsel for FDA. [44 FR 22348, Apr. 13, 1979, as amended at 54 FR 9035, Mar. 3, 1989]

§ 13.20

Submissions to a Board.

(a) Submissions are to be filed with the Division of Dockets Management under § 10.20. (b) The person making a submission shall serve copies of it on each participant in the proceeding, except as provided in §§ 13.10(b)(2) and 13.45. Submissions of documentary data and information need not be sent to each participant, but any accompanying transmittal letter, summary, statement of position, certification under paragraph (d) of this section, or similar document must be. (c) A submission must be mailed to the address shown in the notice of appearance or personally delivered. (d) All submissions are to be accompanied by a certificate of service, or a statement that service is not required. (e) No written submission or other portion of the administrative record may be held in confidence, except as provided in §§ 13.10(b)(2) and 13.45. (f) A participant who believes that compliance with the requirements of this section constitutes an unreasonable financial burden may submit to the Commissioner a petition to participate in forma pauperis in the form and manner specified in § 12.82.

§ 13.25

Disclosure of data and information by the participants.

(a) Before the notice of hearing is published under § 13.5, the director of the center responsible for the matters involved in the hearing must submit to the Division of Dockets Management— (1) The relevant portions of the existing administrative record of the proceeding. Portions of the administrative record not relevant to the issues in the hearing are not part of the administrative record; (2) A list of all persons whose views will be presented orally or in writing at the hearing; Files(3) All documents in the director's files containing factual information, whether favorable or unfavorable to the director's position, which relate to the issues involved in the hearing. means the principal files in the center in which documents relating to the issues in the hearing are ordinarily kept, e.g., the food additive master file and the food additive petition in the case of issues concerning a food additive, or the new drug application in the case of issues concerning a new drug. Internal memoranda reflecting the deliberative process, and attorney work product and material prepared specifically for use in connection with the hearing, are not required to be submitted; (4) All other…

§ 13.30

Proceedings of a Board.

(a) The purpose of a Board is to review medical, scientific, and technical issues fairly and expeditiously. The proceedings of a Board are conducted as a scientific inquiry rather than a legal trial. (b) A Board may not hold its first hearing until after all participants have submitted the information required by § 13.25. (c) The Chairman calls the first hearing of the Board. Notice of the time and location of the first hearing is to be published at least 15 days in advance and the hearing will be open to the public. All participants will have an opportunity at the first hearing to make an oral presentation of the information and views which in their opinion are pertinent to the resolution of the issues being considered by a Board. A participant's presentation may be made by more than one person. The Chairman determines the order of the presentation. Participants may not interrupt a presentation, but members of the Board may ask questions. At the conclusion of a presentation, each of the other participants may briefly comment on the presentation and may request that the Board conduct further questioning on specified matters. Members of the Board may then ask further questions.…

§ 13.40

Administrative record of a Board.

(a) The administrative record of a hearing before a Board consists of the following: Federal Register04(1) All relevant notices. (2) All written submissions under § 13.20. (3) The transcripts of all hearings of the Board. (4) The initial decision of the Board. (b) The record of the administrative proceeding is closed— (1) Relevant to receiving information and data, at the time specified in § 13.30(i); and (2) Relevant to pleadings, at the time specified in § 13.30(i) for filing a written statement of position with proposed findings and conclusions. (c) The Board may, in its discretion, reopen the record to receive further evidence at any time before filing an initial decision.

§ 13.45

Examination of administrative record.

(a) The availability for public examination and copying of each document which is a part of the administrative record of the hearing is governed by § 10.20(j). Each document available for public examination or copying is placed on public display in the office of the Division of Dockets Management promptly upon receipt in that office. (b) Lists of nominees and comments submitted on them under § 13.10(b)(3) are not subject to disclosure unless they become an issue in a court proceeding.

§ 13.5

Notice of a hearing before a Board.

Federal Register04If the Commissioner determines that a Board should be established to conduct a hearing on any matter, a notice of hearing will be published in the setting forth the following information: (a) If the hearing is under § 13.1 (a) or (b), all applicable information described in § 12.32(e). Federal Register04(1) Any written document that is to be the subject matter of the hearing will be published as a part of the notice, or the notice will refer to it if the document has already been published in the or state that the document is available from the Division of Dockets Management or an agency employee designated in the notice. (2) For purposes of a hearing under § 13.1 (a) or (b), all participants who file a notice of participation under § 12.32(e)(6)(ii) are deemed to be parties and entitled to participate in selection of the Board under § 13.15(b). (b) If the hearing is in lieu of a formal evidentiary hearing, as provided in § 13.1(c), all of the information described in § 12.32(e). [44 FR 22348, Apr. 13, 1979, as amended at 47 FR 26375, June 18, 1982]

§ 13.50

Record for administrative decision.

The administrative record of the hearing specified in § 13.40(a) constitutes the exclusive record for decision.

Regulatory Context

This document sits within United States CFR and is most useful when linked to operational submission, quality, and inspection workflows.

United StatesCFR

Related Terms

Operational Use Cases

Related Actions